Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent GlioblastomaBATCHELOR, Tracy T ; DUDA, Dan G ; LOUIS, David N ; COHEN, Kenneth S ; CHEA, Houng ; EXARHOPOULOS, Alexis ; LOEFFLER, Jay S ; MOSES, Marsha A ; IVY, Percy ; SORENSEN, A. Gregory ; WEN, Patrick Y ; JAIN, Rakesh K ; DI TOMASO, Emmanuelle ; ANCUKIEWICZ, Marek ; PLOTKIN, Scott R ; GERSTNER, Elizabeth ; EICHLER, April F ; DRAPPATZ, Jan ; HOCHBERG, Fred H ; BENNER, ThomasJournal of clinical oncology, 2010-06, Vol.28 (17), p.2817-2823 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
|
2 |
Material Type: Artigo
|
Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort studyChheda, Milan G. ; Wen, Patrick Y. ; Hochberg, Fred H. ; Chi, Andrew S. ; Drappatz, Jan ; Eichler, April F. ; Yang, Daniel ; Beroukhim, Rameen ; Norden, Andrew D. ; Gerstner, Elizabeth R. ; Betensky, Rebecca A. ; Batchelor, Tracy T.Journal of neuro-oncology, 2015-02, Vol.121 (3), p.627-634 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |
|
3 |
Material Type: Artigo
|
A phase II trial of oral gimatecan for recurrent glioblastomaHu, Jethro ; Wen, Patrick Y. ; Abrey, Lauren E. ; Fadul, Camilo E. ; Drappatz, Jan ; Salem, Nadia ; Supko, Jeffrey G. ; Hochberg, FredJournal of neuro-oncology, 2013-02, Vol.111 (3), p.347-353 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |